It has been shown that in vitro treatment with Irisin on human chondrocytes, obtained from patients with osteoarthritis, increases the synthesis of glycosaminoglycans and type II collagen and reduces the expression of type X collagen and some inflammatory cytokines, such as interleukins 1 and 6 [14]. The gene discussed is FNDC5; the disease is osteoarthritis.